Citigroup’s Pharvaris PHVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$79.7K Sell
2,304
-138
-6% -$4.17K ﹤0.01% 4801
2026
Q1
$69K Buy
2,442
+655
+37% +$17.5K ﹤0.01% 4413
2025
Q4
$49.6K Buy
1,787
+1,223
+217% +$29.5K ﹤0.01% 4579
2025
Q3
$14.1K Buy
564
+7
+1% +$155 ﹤0.01% 4925
2025
Q2
$9.8K Buy
557
+14
+3% +$226 ﹤0.01% 5191
2025
Q1
$8.53K Hold
543
﹤0.01% 5217
2024
Q4
$10.4K Buy
+543
New +$11.2K ﹤0.01% 5375

Other funds holding PHVS

Citigroup's PHVS Position: Q2 2026 in Review

Citigroup reduced its Pharvaris (PHVS) stake by 5.7% in Q2 2026, selling an estimated $4.17K and leaving 2,304 shares worth $79.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4801.

Citigroup first reported a position in PHVS in Q4 2024 and has held it in 7 quarters since. 23 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • Citigroup held 2,304 shares of Pharvaris worth $79.7K as of Q2 2026.
  • Citigroup sold 138 Pharvaris shares in Q2 2026, an estimated $4.17K.
  • Pharvaris made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4801 holding.
  • Citigroup first reported a position in Pharvaris in Q4 2024 and has held it in 7 quarters since.
  • 23 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.